Phase 1 trial just opened for recruitment. Still a long way to Phase 3.
And then the approval processes: North America, UK, EU, China, Asia, Australia, and everyhere between. Each with their own rules on marketing of drugs! For example, Australia and the UK do not allow direct marketing to patients (thank goodness).
Where does one even start? Phase 1 sounds good to me!
Add to My Watchlist
What is My Watchlist?
